Preliminary experience with a terpene mixture versus ibuprofen for treatment of category III chronic prostatitis/chronic pelvic pain syndrome

World Journal of Urology

Volumn 24, Issue 1, 2006, Pages 55-60

  Lee, Choong Bum ^a   Ha, U Syn ^a   Lee, Seung Ju ^b   Kim, Sae Woong ^c   Cho, Yong Hyun ^c  

^a The Catholic University of Korea   (South Korea)

^b Sam Hospital   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Chronic prostatitis; Terpenes

Indexed keywords

IBUPROFEN; ROWATINEX; TERPENE;

ADULT; ARTICLE; CHI SQUARE DISTRIBUTION; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; FOLLOW UP; HEALTH SURVEY; HOSPITALIZATION; HUMAN; MALE; PELVIS PAIN SYNDROME; PROBABILITY; PROSTATITIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; SYNDROME; TREATMENT OUTCOME;

ADULT; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HEALTH STATUS INDICATORS; HUMANS; IBUPROFEN; MALE; PELVIC PAIN; PROBABILITY; PROSTATITIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; SYNDROME; TERPENES; TREATMENT OUTCOME;

EID: 33644537915     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-005-0039-x     Document Type: Article

References (25)

1. Buck AC, Rees RW, Ebeling L (1989) Treatment of chronic prostatitis and prostatodynia with pollen extract. Br J Urol 64:496-499
2. Couladis M, Chinou IB, Tzakou O, Petrakis PV (2003) Composition and antimicrobial activity of the essential oil of Hypericum rumeliacum subsp. apollinis (Boiss. & Heldr.). Phytother Res 17:152-154
3. Juergens UR, Stober M, Vetter H (1998) Inhibition of cytokine production and arachidonic acid metabolism by eucalyptol (1.8-cineole) in human blood monocytes in vitro. Eur J Med Res 3:508-510
4. Litwin MS, McNaughton-Collins M, Fowler FJ Jr, Nickel JC, Calhoun EA, Pontari MA, et al (1999) The national institutes of health chronic prostatitis symptom index: Development and validation of a new outcome measure. J Urol 162:369-375
5. Magoha GA (1996) Ten years experience with chronic prostatitis in Africans. East Afr Med J 73:176-178
6. Martin S, Padilla E, Ocete MA, Galvez J, Jimenez J, Zarzuelo A (1993) Anti-inflammatory activity of the essential oil of Bupleurum fruticescens. Planta Med 59:533-536
7. McNaughton Collins M, MacDonald R, Wilt TJ (2000) Diagnosis and treatment of chronic abacterial prostatitis: A systematic review. Ann Intern Med 133:367-381
8. Meares EM, Stamey TA (1968) Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 5:492-518
9. Nickel JC (1998) Effective office management of chronic prostatitis. Urol Clin North Am 25:677-684
10. Nickel JC (1999) Prostatitis: Evolving management strategies. Urol Clin North Am 26:737-751
11. Nickel JC (1998) Prostatitis myths and realities. Urology 51:362-366
12. Nickel JC, Downey J, Hunter D, Clark J (2001) Prevalence of prostatitis-like symptoms in a population based study using the national institutes of health chronic prostatitis symptom index. J Urol 165:842-845
13. Park TJ, Park YS, Lee TG, Ha H, Kim KT (2003) Inhibition of acetylcholine-mediated effects by borneol. Biochem Pharmacol 65:83-90
14. Rugendorff EW, Weidner W, Ebeling L, et al (1993) Results of treatment with pollen extract (cernilton N) in chronic prostatitis and prostatodynia. Br J Urol 71:433-438
15. Sadraei H, Asghari GR, Hajhashemi V, Kolagar A, Ebrahimi M (2001) Spasmolytic activity of essential oil and various extracts of Ferula gummosa Boiss. on ileum contractions. Phytomedicine 8:370-376
16. Sato M, Miyazaki T, Kambe F, et al (1997) Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. J Rheumatol 24:1680-1684
17. Satyanarayana K, Shoskes DA (1997) A molecular injury-response model for the understanding of chronic disease. Mol Med Today 3:331-334
18. Schaeffer AJ (2004) Etiology and management of chronic pelvic pain syndrome in men. Urology 63:75-84
19. Schaeffer AJ, Knauss JS, Landis JR, et al (2002) Chronic prostatitis collaborative research network study group. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: The national institutes of health chronic prostatitis cohort study. J Urol 168:1048-1053
20. Shoskes DA (1998) Effect of the bioflavonoids quercetin and curcumin on ischemic renal injury: A new class of renoprotective agents. Transplantation 66:147-152
21. Shoskes DA (2002) Phytotherapy and other alternative forms of care for the patient with prostatitis. Curr Urol Rep 3:330-334
22. Shoskes DA (2002) Phytotherapy in chronic prostatitis. Urology 60:35-37
23. Shoskes DA (1999) Use of the bioflavonoid quercetin in patients with long-standing chronic prostatitis. J Am Neutraceut Assoc 2:18-21
24. Shoskes DA, Zeitlin SI, Shahed A, et al (1999) Quercetin in men with category III chronic prostatitis: A preliminary prospective, double-blind, placebo-controlled trial. Urology 54:960-963
25. Zhou JY, Tang FD, Mao GG, Bian RL (2004) Effect of alpha-pinene on nuclear translocation of NF-kappa B in THP-1 cells. Acta Pharmacol Sin 25:480-484